Literature DB >> 27942679

Humanized archaeal ferritin as a tool for cell targeted delivery.

Valeria de Turris1, Matilde Cardoso Trabuco2, Giovanna Peruzzi1, Alberto Boffi3, Claudia Testi1, Beatrice Vallone4, Linda Celeste Montemiglio5, Amédée Des Georges6, Lorenzo Calisti5, Irene Benni5, Alessandra Bonamore5, Paola Baiocco1.   

Abstract

Human ferritins have been extensively studied to be used as nanocarriers for diverse applications and could represent a convenient alternative for targeted delivery of anticancer drugs and imaging agents. However, the most relevant limitation to their applications is the need for highly acidic experimental conditions during the initial steps of particle/cargo assembly, a process that could affect both drug stability and the complete reassembly of the ferritin cage. To overcome this issue the unique assembly of Archaeoglobus fulgidus ferritin was genetically engineered by changing a surface exposed loop of 12 amino acids connecting B and C helices to mimic the sequence of the analogous human H-chain ferritin loop. This new chimeric protein was shown to maintain the unique, cation linked, association-dissociation properties of Archaeoglobus fulgidus ferritin occurring at neutral pH values, while exhibiting the typical human H-homopolymer recognition by the transferrin receptor TfR1. The chimeric protein was confirmed to be actively and specifically internalized by HeLa cells, thus representing a unique nanotechnological tool for cell-targeted delivery of possible payloads for diagnostic or therapeutic purposes. Moreover, it was demonstrated that the 12 amino acids' loop is necessary and sufficient for binding to the transferrin receptor. The three-dimensional structure of the humanized Archaeoglobus ferritin has been obtained both as crystals by X-ray diffraction and in solution by cryo-EM.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27942679     DOI: 10.1039/c6nr07129e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  8 in total

1.  Excimer based fluorescent pyrene-ferritin conjugate for protein oligomerization studies and imaging in living cells.

Authors:  Irene Benni; Matilde Cardoso Trabuco; Enrico Di Stasio; Alessandro Arcovito; Alberto Boffi; Francesco Malatesta; Alessandra Bonamore; Simone De Panfilis; Valeria de Turris; Paola Baiocco
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

Review 2.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

3.  Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer Cells.

Authors:  Natalia Pediconi; Francesca Ghirga; Cristina Del Plato; Giovanna Peruzzi; Constantinos M Athanassopoulos; Mattia Mori; Maria Elisa Crestoni; Davide Corinti; Franco Ugozzoli; Chiara Massera; Alessandro Arcovito; Bruno Botta; Alberto Boffi; Deborah Quaglio; Paola Baiocco
Journal:  Bioconjug Chem       Date:  2021-05-12       Impact factor: 4.774

4.  Cryo-EM structure of the human ferritin-transferrin receptor 1 complex.

Authors:  Linda Celeste Montemiglio; Claudia Testi; Pierpaolo Ceci; Elisabetta Falvo; Martina Pitea; Carmelinda Savino; Alessandro Arcovito; Giovanna Peruzzi; Paola Baiocco; Filippo Mancia; Alberto Boffi; Amédée des Georges; Beatrice Vallone
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

5.  Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells.

Authors:  Federica Palombarini; Silvia Masciarelli; Alessio Incocciati; Francesca Liccardo; Elisa Di Fabio; Antonia Iazzetti; Giancarlo Fabrizi; Francesco Fazi; Alberto Macone; Alessandra Bonamore; Alberto Boffi
Journal:  J Nanobiotechnology       Date:  2021-06-09       Impact factor: 10.435

6.  Serum ferritin and primary lung cancer.

Authors:  Zhongqing Chen; Bo Zhu; Chao Ou; Yuxuan Li
Journal:  Oncotarget       Date:  2017-10-04

7.  Engineered ferritin for lanthanide binding.

Authors:  Lorenzo Calisti; Matilde Cardoso Trabuco; Alberto Boffi; Claudia Testi; Linda Celeste Montemiglio; Amédée des Georges; Irene Benni; Andrea Ilari; Bartłomiej Taciak; Maciej Białasek; Tomasz Rygiel; Magdalena Król; Paola Baiocco; Alessandra Bonamore
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

8.  Integrin α2β1-targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy.

Authors:  Chia-Pao Chuang; Yan-Jun Chen; Hsu-Yuan Wang; Chiun-Wei Huang; Jia-Jia Lin; Chiung-Yin Huang; Kuo-Chen Wei; Feng-Ting Huang
Journal:  J Nanobiotechnology       Date:  2021-06-13       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.